Deciphera Pharmaceuticals raises Series B Round to over $90M
Deciphera Pharmaceuticals, a Waltham, MA-based clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments, has increased the size of its Series B financing to over $90m. The Series B was led by New Leaf Venture Partners and joined by…